Medical Science Liaisons (MSLs) are crucial for maintaining relationships with KOLs and serving as medical and scientific experts when it comes to understanding and discussing product characteristics and clinical data. In recent years, the role of MSLs has evolved to include account management, greater interactions with clinical teams/CROs and other strategic roles. With the evolution of the MSL role and the need for maintaining regulatory compliance in all medical affairs functions, there is a demand to support, train and prepare MSL teams to be successful in every aspect of their job. This will allow fruitful interactions with community physicians, academic centers, hospitals, insurance companies and internal stakeholders.
The 16th Medical Science Liaisons Best Practices Congress addresses the evolving role of the MSL in the current pharmaceutical landscape, including the impact of compliance and risk mitigation, novel approaches to performance metrics, how to overcome communication challenges when working with multiple teams, ways to maximize the role of the MSL to increase the productivity of CROs and clinical research teams, and how to prioritize and maintain relationships with KOLs and other fundamental stakeholders. Additionally, it will equip you with tools to develop successful MSL training and career progression programs that will optimize MSLs’ jobs and help MSL leadership work toward achieving higher retention of MSL teams.
This conference is designed for representatives from pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas: